Skip to main content

Table 1 Patient and tumor characteristics

From: FDG-PET/CT in predicting aggressiveness of rectal cancer

Characteristic Number [%]
Age median, range 60 [32–86]
Sex  
Male 19 [57.57%]
Female 14 [42.42 %]
Location  
Upper rectum 19 [57.6%]
Middle rectum 3 [9.1%]
Lower rectum 7 [21.2%]
Mid and lower rectum 4 [12.1]
Histopathology  
Moderately differentiated 19 [57.6%]
Poorly differentiated 10 [30.3%]
Mucinous adenocarcinoma 4 [12.1%]
Clinical stage  
II 10 [30.3%]
IIIA 6 [18.2%]
IV 17 [51.5%]
T stage  
T3 32 [96.96 %]
T4 1 [3.03%]
N stage  
N0 13 [39.3%]
N1 12 [36.36%]
N2 8 [24.24%]
FDG-PET/CT results, median, range  
SUVmax 17.9 [5.3–53.82]
SUV mean 10.46 [2.7–40.5]
MTV 21.5 [3.9–62.5]
TLG 234.442 [36.9–2521.1]
  1. SUV standard uptake value, MTV metabolic tumor volume, TLG total lesion glycolysis